Name That Brand

Can you name the brand? Each month we print part of a popular pharmaceutical product or advertisement, along with some clues to its identity. Readers are invited to name the brand for a chance to win a copy of Medicine Avenue II. Please e-mail your answer to NameThatBrand@haymarketmedia.com or fax 646-638-6150. The deadline is October 31, 2011. The winner will be selected randomly from all the correct entries.

Brand X does its best to stay afloat

This month's Mystery Brand (Brand.com pictured) has had a rather rough time of late, as a cunning plan for surfing past a close competitor's patent expiration and into continued growth instead dragged it under the waves. Will docs condemn it to the Davy Jones' Locker of TRx share as a cheaper, tried-and-true alternative sheds its name brand pricing? Well, doctors being creatures of habit, probably not, but at best, they're looking at a leveling off of new prescriptions and forbidding growth prospects going forward.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.